secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bausch & Lomb Corp (BLCO)
CIK:        0001860742
Form:       8-K
Filed at:   2026-04-29T23:59:59+00:00
Accession:  0001860742-26-000060
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bausch + Lomb Q1 2026 revenue $1.244B (+9% YoY), raises full-year guidance
--------------------------------------------------------------------------

- Revenue $1.244B, up 9% reported and 6% constant currency YoY; GAAP net loss narrowed to $71M from $212M.
- Adjusted EBITDA (non-GAAP) $189M vs $98M prior year; adjusted EPS $0.05 vs -$0.15.
- Raising 2026 revenue guidance to $5.42B-$5.52B (was $5.375B-$5.475B) and Adj. EBITDA ex-IPR&D to $1.01B-$1.06B.
- Pharmaceuticals segment grew 12% constant currency; MIEBO (+33%) and XIIDRA (+30%) led growth.
- Vision Care +5% constant currency; Surgical +1% constant currency; double-digit growth in daily SiHy lenses.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1860742/000186074226000060/0001860742-26-000060-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1860742/000186074226000060/blco-20260429.htm
  HTML page:      https://secwatch.observer/filing/0001860742-26-000060

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer